Back to results
US 7,396,933 B2Granted
Quinolinone-carboxamide compounds
AssigneeTheravance, Inc.
InventorsSeok-Ki Choi, Paul Fatheree, Roland Gendron, Adam A Goldblum, Lan Jiang, Daniel D Long, Daniel Marquess
Life of this patent
Estimating the term…
Abstract
The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
Claims13
A compound of formula (I):
- wherein:
- R1 is hydrogen, halo, hydroxy, C1-4alkyl, or C1-4alkoxy;
- R2 is C3-4alkyl or C3-6cycloalkyl;
- R3 is hydroxy, C1-3alkoxy, hydroxy-substituted C1-4alkyl, or —OC(O)NRaRb;
- R4 is hydrogen or C1-4alkyl;
- X is selected from —N(R8)C(O)R9, —N(R8)S(O)2R10, —S(R11)O2, —N(R8)C(O)OR12, —N(R8)C(O)NR13R14, —N(R8)SO2NR13R14, —C(O)NR13R14, —OC(O)NR13R14, —C(O)OR12, —OR15, and cyano;
- R5 is hydrogen or C1-4alkyl, wherein C1-4alkyl is optionally substituted with hydroxy, C1-3alkoxy, or cyano;
- R6 and R7 are independently selected from hydrogen, hydroxy, halo, and C1-4alkyl, wherein C1-4alkyl is optionally substituted with hydroxy or C1-3alkoxy;
- R8 is hydrogen or C1-4alkyl;
- or R5 and R8, R5 and R6, or R6 and R8 taken together form C2-5alkylenyl, wherein C2-5alkylenyl is optionally substituted with hydroxy, halo, hydroxy-substituted C1-3alkyl, or C1-3alkoxy;
- or R3 and R5 taken together form —OCH2CH2—;
- or R5 and R6 taken together form —(CH2)q—Q—(CH2)q, wherein Q is oxygen or sulfur and q is independently 0, 1, or 2;
- R9 is hydrogen, furanyl, or C1-4alkyl, wherein C1-4alkyl is optionally substituted with hydroxy or with from 1 to 3 halo;
- R10 is hydrogen or C1-4alkyl, wherein C1-4alkyl is optionally substituted with —SO2Rc, C3-6cycloalkyl or with from 1 to 3 halo;
- or R8 and R10 taken together form C3alkylenyl;
- R11 is hydrogen, C1-4alkyl, or —NRbRc;
- or R5 and R11 or R6 and R11 taken together form C2-5alkylenyl;
- R12, R13, and R14 are independently hydrogen or C1-4alkyl;
- R15 is hydrogen or C1-4alkyl, wherein C1-4alkyl is optionally substituted with hydroxy;
- Ra, Rb, and Rc are independently hydrogen or C1-3alkyl;
- and
- n is 1, 2, 3, or 4;
- provided that when n is 1, X forms a carbon-carbon bond with the carbon atom bearing the substituents R6 and R7;
- or a pharmaceutically-acceptable salt or stereoisomer thereof.
21 more elements
A process for preparing a compound of formula (I):
- wherein R3 is hydroxy, and R1, R2, R4, R5, R6, R7, n, and X are defined as in claim 1, or a salt or stereoisomer thereof, the process comprising:
- step (a) or step (b) as defined in claim 13, or
- (c) reacting a compound of formula (X):
- or a salt thereof, with a compound of formula (VII) and a compound of formula (XI):
- wherein L is a leaving group;
- or
- (d) reacting a compound of formula (X) with a compound of formula (XII):
- to provide a compound of formula (I), or a salt or stereoisomer thereof.
5 more elements
Dependencies are inferred from the claim text.